SCHOTT in the news
Global technology exploration and innovation
Tamtam found 20 recent articles about SCHOTT.
- Arbeiten bei SCHOTT in Mitterteich: ein starkes Team für besondere Produkte
SCHOTT's Mitterteich plant is seeking 40 new production employees to join its team, focusing on high-quality pharmaceutical glass manufacturing and emphasizing strong teamwork and employee development.
- Ultradünn und großformatig: SCHOTT® Solar Glass exos startet in Formaten bis 2 × 1 Meter
SCHOTT has launched larger formats, up to 2 x 1 meter, of its ultrathin SCHOTT® Solar Glass exos for demanding space photovoltaic applications, supporting advanced satellite energy needs and automated manufacturing.
- SCHOTT Solar Glass exos startet in Formaten bis 2 × 1 Meter
SCHOTT AG has expanded its ultra-thin Solar Glass exos for space photovoltaics to larger formats, up to 2 x 1 meters, to meet the growing power demands of satellites.
- Schott Pharma-Aktie: UBS warnt vor Risiken bei Glasspritzen
UBS downgraded Schott Pharma's stock due to anticipated risks in demand for glass syringes, particularly GLP-1 related products, which are expected to impact future revenue and profit forecasts.
- CFO-News: Schott, Deutz, Degussa
Schott appoints Marc Horn as its new CFO, replacing Marcus Knöbel who moves to an operational role, as Andrea Frenzel exits the board.
- Schott appoints new CFO
Schott appoints Marc Horn as its new CFO, effective January 1, 2027, as Dr. Andrea Frenzel departs and Marcus Knöbel takes on new operational responsibilities.
- Schott Pharma-Aktie notiert am Mittwochmittag bei Lang & Schwarz
Schott Pharma's stock traded at 21.25 Euros on November 11, 2026, and its annual financial statements are due on December 10, 2026.
- 30.000 Euro für Otto-Schott-Institut für Materialforschung
SCHOTT AG donates 30,000 Euros to the Otto Schott Institute for Materials Research at Friedrich Schiller University Jena to foster science and innovation.
- Merck-Manager wird CFO von Schott
Marc Horn from Merck will be Schott's new CFO, while current CFO Marcus Knöbel moves to an operational role, replacing Andrea Frenzel who is leaving for family reasons.
- Schott Pharma stock trades at 21.30 euros in Tuesday session
Schott Pharma stock traded at 21.30 euros on November 10, 2026, as an intraday quote.
- UBS turns cautious on Schott Pharma as glass syringe demand risks mount
UBS downgraded Schott Pharma to 'neutral' due to risks of decreased glass syringe demand in 2027 and 2028, leading to a lowered price target and revised earnings forecasts.
- Schott Pharma fällt 5 %: UBS stuft ab und warnt vor Nachfragerisiko bei Glasspritzen
UBS downgraded Schott Pharma, citing potential demand risks for glass syringes and lowered its price target and earnings forecasts, leading to a stock decline.
- Die Talfahrt von Schott Pharma setzt sich nach der Abstufung durch UBS fort
UBS downgraded Schott Pharma's stock to 'Neutral' and reduced its price target, citing concerns about market slowdowns, particularly in GLP-1 related business, following Stevanato's revised outlook.
- Schott Pharma-Aktie: Nächste Unternehmenstermine im November
SCHOTT Pharma, a provider of injectable drug solutions, has upcoming investor conferences in November 2026 and reported 4 million Euros in Free Cashflow for fiscal year 2025.
- UBS stuft Schott Pharma auf 'Neutral'
UBS downgraded Schott Pharma to 'Neutral' and cut its price target due to revised forecasts and potential lower demand for glass syringes.
- UBS streicht Kaufempfehlung: SCHOTT Pharma bricht ein
UBS downgraded SCHOTT Pharma to "Neutral" and lowered its price target due to a competitor's revised forecast, causing a significant stock decline.
- SCHOTT Pharma AG & Co. KGaA : UBS is now Neutral
UBS downgraded SCHOTT Pharma AG & Co. KGaA's rating to Neutral and reduced its target price to EUR 22.30.
- Stefan Brandl neuer CEO von Schott
Stefan Brandl was appointed as the new CEO of Schott, bringing significant international leadership experience to the role, succeeding Torsten Derr.
- Schott Pharma stock last traded at 21.73 euros on Friday
Schott Pharma's stock traded at 21.73 euros on Friday, with its business focused on injectable drug packaging solutions.
- Stefan Brandl Named New CEO of Schott
Stefan Brandl is the new CEO of Schott, with a focus on strengthening international competitiveness and innovation, following Torsten Derr's resignation.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like SCHOTT?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies